Prosecution Insights
Last updated: November 20, 2026
Application No. 18/935,810

Variable Wall Thickness Balloon for Crimp Profile Reduction and Balloon Shapes for Valve Inflation Stability

Non-Final OA §102§103
Filed
Nov 04, 2024
Priority
Dec 26, 2023 — provisional 63/614,744
Examiner
STEWART, ALVIN J
Art Unit
3774
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Abbott Laboratories
OA Round
1 (Non-Final)
82%
Grant Probability
Favorable
1-2
OA Rounds
9m
Est. Remaining
83%
With Interview

Examiner Intelligence

Grants 82% — above average
82%
Career Allowance Rate
919 granted / 1118 resolved
+12.2% vs TC avg
Minimal +1% lift
Without
With
+0.8%
Interview Lift
resolved cases with interview
Typical timeline
2y 10m
Avg Prosecution
31 currently pending
Career history
1160
Total Applications
across all art units

Statute-Specific Performance

§101
1.9%
-38.1% vs TC avg
§103
37.1%
-2.9% vs TC avg
§102
35.1%
-4.9% vs TC avg
§112
14.7%
-25.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1118 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-3 and 5 are rejected under 35 U.S.C. 102 (a)(1) as being anticipated by Crocker et al US Patent Pub. 2005/0261722A1. Crocker et al discloses a system capable for delivering a prosthetic heart valve, the delivery system comprising: a handle (14); a delivery catheter (10) extending from the handle; and a balloon (50) on a distal portion of the catheter, the balloon having a proximal portion (62), a distal portion (58), and a central portion (60) positioned between the proximal portion and the distal portion, the central portion configured to receive the prosthetic heart valve in a crimped condition thereon, wherein the proximal portion has a proximal wall thickness, the distal portion has a distal wall thickness, and the central portion has a central wall thickness, the central wall thickness being smaller than the proximal wall thickness and smaller than the distal wall thickness. See Fig. 6 and paragraph 64. Regarding claim 2, see Fig. 6 and paragraph 64. Regarding claim 3, see Fig. 6 showing the portions formed integrally with each other. Regarding claim 5, see paragraph 64 disclosing a 70%, since the value of the thicknesses are disclosed. Claims 11-15 are rejected under 35 U.S.C. 102(a)(2) as being anticipated by Theisen et al US patent Pub. 2024/0148501A1. The applied reference has a common assignee with the instant application. Based upon the earlier effectively filed date of the reference, it constitutes prior art under 35 U.S.C. 102(a)(2). This rejection under 35 U.S.C. 102(a)(2) might be overcome by: (1) a showing under 37 CFR 1.130(a) that the subject matter disclosed in the reference was obtained directly or indirectly from the inventor or a joint inventor of this application and is thus not prior art in accordance with 35 U.S.C. 102(b)(2)(A); (2) a showing under 37 CFR 1.130(b) of a prior public disclosure under 35 U.S.C. 102(b)(2)(B) if the same invention is not being claimed; or (3) a statement pursuant to 35 U.S.C. 102(b)(2)(C) establishing that, not later than the effective filing date of the claimed invention, the subject matter disclosed in the reference and the claimed invention were either owned by the same person or subject to an obligation of assignment to the same person or subject to a joint research agreement. Theisen et al discloses a system for delivering a prosthetic heart valve (See Figs. 5A-B, PHV), the delivery system comprising: a handle (not shown); a delivery catheter (504) extending from the handle; and a balloon (550) on a distal portion (502) of the catheter, the balloon having a proximal portion, a distal portion, and a central portion (see Fig. 5A) positioned between the proximal portion and the distal portion. The central portion (554) configured to receive the prosthetic heart valve in a crimped condition thereon, wherein when the balloon is in an inflated or blown state, the proximal portion has a proximal outer diameter, the distal portion has a distal outer diameter, and the central portion has a central outer diameter that is smaller than the proximal outer diameter and smaller than the distal outer diameter. See paragraph 40 disclosing that the shoulders hold the implant during traction and expansion. Regarding claim 12, see Figs. 5A-B showing that the claimed portions are integral one to the other. Regarding claim 13, see Fig. 5A disclosing a heart valve and overlying only the central portion. Regarding claims 14 and 15, see Fig. 5 and paragraph 40 disclosing the formation of shoulders before and after the expansion of the balloon. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 6 and 7 are rejected under 35 U.S.C. 103 as being unpatentable over Crocker et al US Patent Pub. 2005/0261722A1. Croker et al discloses the invention substantially as claimed. However, Crocker et al does not disclose a central wall thickness about 50% of the proximal wall thickness and a prosthetic heart valve. Regarding the wall thickness, it would have been obvious to one having ordinary skill in the art at the time the invention was made to have a wall thickness about 50%, since it has been held that finding an optimum value of a result effective variable involves only routine skill in the art. In re Boesch, 617 F. 2d 272, 205 USPQ 215 (CCPA 1980). Regarding the heart valve, it is well known in the art to have heart valves made with the same frame structure as stents and use balloon to expand heart valves into the heart, therefore, it would have been obvious to one ordinary skill in the art to use the balloon catheter of the Crocker et al reference with an expandable heart valve in order to deploy a heart valve inside the patient’s heart. Claims 4, 8-10 and 16-20 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. US Pub. 2025/0064587A1 See Fig. 6 disclosing heart valve in balloon expandable catheter. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ALVIN J STEWART whose telephone number is (571)272-4760. The examiner can normally be reached Monday-Friday 8:30AM-6PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Thomas Barrett can be reached at 571-272-4746. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ALVIN J STEWART/Primary Examiner, Art Unit 3799 11/10/26
Read full office action

Prosecution Timeline

Nov 04, 2024
Application Filed
Nov 13, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12773313
TRANSLUMINAL DELIVERY SYSTEM
3y 4m to grant Granted Oct 27, 2026
Patent 12758391
TALUS IMPLANT
4y 5m to grant Granted Oct 13, 2026
Patent 12758403
BIONIC JOINT AND A PROSTHESIS FOR REPLACING AN ELBOW JOINT
3y 0m to grant Granted Oct 13, 2026
Patent 12751844
UNCAGING STENT
2y 6m to grant Granted Oct 06, 2026
Patent 12746121
TRANS-SEPTAL DELIVERY SYSTEM AND METHODS OF USE
3y 6m to grant Granted Sep 29, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
82%
Grant Probability
83%
With Interview (+0.8%)
2y 10m (~9m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1118 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month